Steve Cordina, MD
Neurology · Mobile, ALNPI 1972777290
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $54,930 of the $68,639 with a category attached, or 80.0%. Genentech USA, Inc. accounts for 73.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $45,871 and has fallen 64.2% since, to $16,440 in 2021. Among neurology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $798.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$50K
- Microvention, Inc.$17K
- Rapid Medical Ltd$897
- Stryker$172
- Medtronic$118
- Eisai Inc.$107
- plus $312 from 12 others
Across 55 payments — averaging $111.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$6K
What the payments were for
- Speaking & faculty fees$54,93080%
- Travel & lodging$12,24418%
- Food & beverage$1,4652%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 38 | $50,156 |
| Microvention, Inc. | 12 | $16,876 |
| Rapid Medical Ltd | 1 | $897 |
| Stryker | 6 | $172 |
| Medtronic(2 entities) | 5 | $118 |
| Eisai Inc. | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| EMD Serono, Inc. | 4 | $54 |
| UCB, Inc. | 2 | $33 |
| Baxter Healthcare | 2 | $31 |
| Lundbeck LLC | 1 | $23 |
| SK Life Science, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Chiesi USA, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB Aneurysm Embolization System$16,284
- Activase$10,680
- Comaneci$897
- WEB$458
How this compares
$68,639 in reported general payments places this provider in the 90th percentile of 255 neurology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Mobile
- Daniel DeesMobile$799K
- Hayden LongMobile$386K
- Charles MarkleMobile$212K
- William KilgoMobile$200K
- Bassam BassamMobile$197K
- Dean NaritokuMobile$160K
- Thomas FosterMobile$51K
- Laura MintoMobile$33K
- Andrew ManleyMobile$33K
- Juan OchoaMobile$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.